Odyssey Therapeutics Inc.
ODTX | NASDAQ
$19.33
-$0.21 (-1.07%)
Nov 2, 2026, 9:56 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Net Income | -52.79M | -38.26M |
Depreciation & Amortization | 1.04M | 1.17M |
Stock-Based Compensation | 5.67M | 2.59M |
Other Working Capital | 1.97M | -7.67M |
Other Non-Cash Items | 10.39M | 659K |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | 1.17M | -7.19M |
Operating Cash Flow | -34.51M | -41.04M |
Capital Expenditures | -186K | -148K |
Cash Acquisitions | n/a | n/a |
Purchase of Investments | n/a | n/a |
Sales Maturities Of Investments | 34.95M | 34.95M |
Other Investing Acitivies | -246.21M | n/a |
Investing Cash Flow | -211.44M | 34.8M |
Debt Repayment | -46K | -24K |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | 291.62M | -143K |
Financial Cash Flow | 292.16M | 484K |
Net Cash Flow | 46.31M | -5.73M |
Free Cash Flow | -34.69M | -41.18M |
Adj. Free Cash Flow | -40.37M | -43.77M |
Maintenance CapEx | -186K | -148K |
Growth CapEx | n/a | n/a |
Owner Earnings | -34.69M | -41.18M |
Add to Watchlist
Select watchlists to add or remove ODTX